chronic inflammatory demyelinating polyneuropathy
GPTKB entity
Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
neurological disorder
|
| gptkbp:abbreviation |
gptkb:CIDP
|
| gptkbp:affects |
peripheral nervous system
both children and adults |
| gptkbp:associatedWith |
demyelination of nerves
|
| gptkbp:cause |
disability
|
| gptkbp:causedBy |
autoimmune response
|
| gptkbp:characterizedBy |
progressive weakness
impaired sensory function |
| gptkbp:diagnosedBy |
clinical examination
lumbar puncture nerve conduction studies |
| gptkbp:firstDescribed |
1975
|
| https://www.w3.org/2000/01/rdf-schema#label |
chronic inflammatory demyelinating polyneuropathy
|
| gptkbp:ICD-10_code |
G61.81
|
| gptkbp:onset |
gradual
|
| gptkbp:prevalence |
rare
|
| gptkbp:relatedTo |
gptkb:Guillain-Barré_syndrome
|
| gptkbp:symptom |
muscle weakness
numbness tingling loss of reflexes |
| gptkbp:treatment |
corticosteroids
intravenous immunoglobulin plasma exchange |
| gptkbp:bfsParent |
gptkb:Guillain-Barré_syndrome
gptkb:Immunovant gptkb:batoclimab |
| gptkbp:bfsLayer |
6
|